Study design | Country | Trial length in month | Number of patients included | Proportion of patients under BP control % | Diastolic BP at recruitment, mmHg | Systolic BP at recruitment, mmHg | Patients with diabetes % | Female % | Mean age | Race | Proportion using antihypertensive medication, % | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Artinian 2007 | RCT | USA | 8 | 387 | 0 | > = 90 | > = 140 | 25.83 | 64.34 | 59.65 | 100% African Americans | 70.54 |
Borenstein 2003 | RCT | USA | 12 | 197 | 0 | > = 90 | > = 140 | 13 | 61 | 62 | 32% African Americans | N/A |
Bosworth 2009 | RCT | USA | 24 | 636 | 73 | di | di | 36 | 66 | 61 | 49% African Americans | 100 |
Bosworth 2011 | RCT | USA | 18 | 591 | 59 | > 90 | > 140 | 43 | 8 | 64 | 48% white | 100 |
Brennan 2010 | RCT | USA | 12 | 638 | 14 | di | di | 26 | 67 | 55.7 | 100% African Americans | 96 |
Garcia-Pena 2001 | RCT | Mexico | 6 | 718 | 0 | > = 90 | > = 160 | 26 | 64 | 70.6 | N/A | 77 |
Green 2008 | RCT | USA | 12 | 778 | 0 | 90–109 | 140–199 | N/A | 52.2 | 59.1 | 82,8% white | 96 |
Hennessy 2006 | cRCT | USA | 6 | 10,696 | 53.29 | di | di | 25.48 | 56.95 | 62.3 | 48% Caucasian | 66.77 |
Hunt 2004 | RCT | USA | 12 | 604 | 0 | 90–99 | 140–159 | 15 | 58 | 69 | 90% white | N/A |
Hunt 2008 | RCT | USA | 12 | 463 | 0 | > = 100 | > = 160 | 25 | 65 | 68 | N/A | N/A |
Johnson 2011 | RCT | USA | 6 | 552 | 0 | di | di | 43 | 65 | 42 | 91% African Americans | 96 |
Kastarinen 2002 | RCT | Finland | 24 | 715 | N/A | 90–109 | 140–179 | N/A | 53 | 54.3 | N/A | 52 |
Lang 1995 | cRCT | France | 18 | 129 | 0 | > 90 | > 140 | N/A | 5 | 43 | N/A | 19 |
Lee 2007 | RCT | Taiwan | 6 | 202 | 0 | N/A | 140–179 | N/A | 42 | 71.3 | N/A | 68 |
Little 2004 | cRCT | USA | 1 | 296 | 0 | > 90 | > 160 | N/A | 44 | 50 | N/A | 0 |
Ma 2014 | RCT | China | 6 | 120 | N/A | di | di | N/A | 50.83 | 58.76 | N/A | 100 |
Magid 2011 | RCT | USA | 6 | 338 | 0 | > 90 (80a) | > 140 (130a) | 54 | 35 | 65.4 | 65% white | 100 |
Margolis 2013 | cRCT | USA | 18 | 450 | 0 | > = 90 | > = 140 | 19.11 | 44.7 | 61.1 | 81.8 white | 73.8 |
McKenney 1973 | RCT | USA | 5 | 50 | 32 | > 90 | N/A | N/A | 76 | 60 | 78% African American | N/A |
McLean 2008 | RCT | Canada | 6 | 227 | 3 | > 80 | > 130 | 100 | 40 | 64.95 | N/A | 66.95 |
Mehos 2000 | RCT | USA | 6 | 36 | 0 | 90–109 | 140–179 | 19.44 | 69.44 | 58.8 | 77.77 Caucasian | 100 |
Morgado 2011 | RCT | Portugal | 9 | 197 | 33 | di | di | 18 | 60 | 59.5 | N/A | 100 |
Roumie 2006 | cRCT | USA | 6 | 1827 | 0 | > = 90 | > 140 | 4.02 | 3 | 65 | N/A | 100 |
Saleem 2015 | RCT | Pakistan | 9 | 385 | 41.8 | di | di | N/A | 31.2 | 39 | N/A | 100 |
Sookaneknun 2004 | RCT | Thailand | 6 | 235 | 20.42 | > = 90 | > = 140 | 44 | 68 | 63.2 | N/A | N/A |
Stewart 2005 | RCT | South Africa | 6 | 83 | N/A | di | di | N/A | N/A | N/A | N/A | N/A |
Tobari 2010 | RCT | Japan | 6 | 132 | 38.63 | 90–109 | 140–179 | N/A | 34 | 61.65 | N/A | 94 |
Tonstad 2007 | RCT | Norway | 6 | 49 | 0 | 90–99 | 140–169 | N/A | 26.53 | 55 | N/A | 16.32 |
Vivian 2002 | RCT | USA | 6 | 56 | 0 | > 90 | > 140 | 51 | 0 | 64.75 | 77.4% African American | 100 |
Wakefield 2011 | RCT | USA | 6 | 302 | N/A | di | di | 100 | 2 | 68 | 96% Caucasian | N/A |
Wal 2013 | RCT | India | 6 | 142 | 0 | > 90 | > 140 | 40.19 | 55.88 | 60.06 | N/A | N/A |
Woollard 1995 | RCT | Australia | 4.5 | 166 | N/A | di | di | N/A | 46.57 | 58.3 | N/A | 100 |
Zabler 2018 | RCT | China | 6 | 59 | N/A | di | di | N/A | 63 | 53.73 | 100% African American | 100 |
Zhu 2017 | RCT | USA | 4 | 134 | 0 | > = 90 | > 140 | 23.9 | 50.7 | 69 | N/A | 81 |
Zillich 2005 | cRCT | USA | 3 | 125 | 0 | di | di | 28 | 61 | 65 | 97.6% white | 100 |